Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-293I14.2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | BCAP31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | FLRT3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | PLOD3 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | CFL2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | ARID3A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | MTHFD2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | SYNC | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
mRNA | LINGO3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | TLR8 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |